Andrew R. Crow

Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo

Rukhsana Aslam, Edwin R. Speck, Michael D. Kim et al. · Blood · 2005 · 475 citations · Full text

Life Sciences, Hematology, Immunology +16

Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk

Anna J. Podolanczuk, Alan H. Lazarus, Andrew R. Crow et al. · Blood · 2008 · 272 citations · Full text

Medicine, Hematology, Pharmacology +7

Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells

Vinayakumar Siragam, Andrew R. Crow, Davor Brinc et al. · Nature Medicine · 2006 · 245 citations

Life Sciences, Cell Biology, Immunology +16

IVIg-mediated amelioration of murine ITP via FcγRIIB is independent of SHIP1, SHP-1, and Btk activity

Andrew R. Crow, Seng Song, John Freedman et al. · Blood · 2003 · 119 citations

Life Sciences, Immunology, Pharmacology +14

IVIg inhibits reticuloendothelial system function and ameliorates murine passive‐immune thrombocytopenia independent of anti‐idiotype reactivity

Andrew R. Crow, Seng Song, John W. Semple et al. · British Journal of Haematology · 2001 · 112 citations · Full text

Life Sciences, Hematology, Immunology +15